5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results
John F. Seymour, Andrew W. Roberts, Dennis A. Carney, Martin J.S. Dyer, Thomas J. Kipps, Michael Hallek, R. Gregory Bociek, Jennifer R. Brown, William G. Wierda, Kanti Rai, Moacyr Ribeiro de Oliveira,Volume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.177
File:
PDF, 71 KB
english, 2011